Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Chicoutimi
Clinical trial register · Canada

Clinical Trials in Chicoutimi, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6567 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:20 UTC
6567
Studies in scope
all four open statuses
3485
Recruiting now
open to new participants
883
Lead sponsors
across recruiting studies
Top sites
Toronto 45 Montreal 27 London 22 Calgary 22 Québec 21

Trials with a site in Chicoutimi

13 of 6567 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
NCT07533019Vitiligo, Non-Segmental Vitiligo (NSV)
Eli Lilly and Company
Phase 2
66
Chicoutimi, London, Ottawa, Richmond Hill, Toronto, Verdun
2026-04-14
Recruiting
Eli Lilly and Company
Phase 3
300
Calgary, Chicoutimi, Edmonton, London, Ottawa, Québec, Vancouver
2026-02-05
Recruiting
Eli Lilly and Company
Phase 2
60
Chicoutimi, Trois-Rivières, Vancouver
2025-12-08
Recruiting
Eli Lilly and Company
Phase 3
7,140
Brampton, Cambridge, Chicoutimi, Hamilton, Laval, Moncton, Montreal, Québec
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
4,500
Calgary, Chicoutimi, Edmonton, Halifax, London, North Bay, Québec, Toronto
2025-10-15
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Chicoutimi, Etobicoke, Hamilton, Joliette, Longueuil, Moncton, Montreal, North York
2025-09-02
Recruiting
Eli Lilly and Company
Phase 2
200
Brampton, Chicoutimi, Hamilton, Longueuil, Moncton, Sarnia, Toronto, Waterloo
2025-03-28
Active, closed
Eli Lilly and Company
Phase 3
1,400
Chicoutimi, Greenfield Park, Kelowna, Lévis, Montreal, Ottawa, Peterborough, Québec
2024-10-24
Active, closed
Eli Lilly and Company
Phase 3
10,000
Calgary, Chicoutimi, Courtice, Edmonton, London, Moncton, North York, Oshawa
2024-04-30
Active, closed
Eli Lilly and Company
Phase 3
17,300
Brampton, Chicoutimi, Hamilton, Joliette, London, Longueuil, Moncton, New Westminster
2024-03-05
Recruiting
Eli Lilly and Company
Phase 3
1,264
Abbotsford British Columbia, Chicoutimi, Vancouver
2023-12-21
Active, closed
Eli Lilly and Company
Phase 3
160
Edmonton, Hamilton, Toronto, Chicoutimi
2023-10-16
Active, closed
Eli Lilly and Company
Phase 3
15,374
Brampton, Calgary, Chicoutimi, Courtice, Greater Sudbury, Halifax, Hamilton, Lévis
2022-10-11
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-canada/city/chicoutimi

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,567 studies in total at the last sync on 17 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies with a site in Chicoutimi that also match the filters currently applied.

How many clinical trials are recruiting in Chicoutimi?

8 of the 13 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Chicoutimi), 13 studies
PhaseStudiesRecruitingShare
Phase 310576.9%
Phase 23323.1%

Most active sponsors

Lead sponsors with the most studies (Chicoutimi)
Lead sponsorStudiesRecruiting
Eli Lilly and Company138
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.